Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy-Reference-Cited by-同舟云学术

Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy

Published:2006-05 Issue:1-2 Volume:174 Page:74-81
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Velicu Simona,Han Yu,Ulasov Ilya,Brown Ian E.,Andaloussi Abdel El,Gajewski Thomas F.,Lesniak Maciej S.

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference38 articles.

1. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells;Blank;Cancer Res.,2004

2. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy;Blank;Cancer Immunol. Immunother.,2005

3. ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo;Blank;J. Immunol.,2005

4. Role of apoptosis for mouse liver growth regulation and tumor promotion: comparative analysis of mice with high (C3H/He) and low (C57Bl/6J) cancer susceptibility;Bursch;Toxicol. Lett.,2004

5. Gene array and protein expression profiles suggest post-transcriptional regulation during CD8+ T cell differentiation;Cham;J. Biol. Chem.,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamer-functionalized quercetin thermosensitive liposomes for targeting drug delivery and antitumor therapy;Biomedical Materials;2022-09-09

2. Layered and orthogonal assembly of hydrophilic drugs and hydrophobic photosensitizers for enhanced cancer therapy;Materials Science and Engineering: C;2021-12

3. Effect of a Drug Delivery System Made of Quercetin Formulated into PEGylation Liposomes on Cervical Carcinoma In Vitro and In Vivo;Journal of Nanomaterials;2021-08-13

4. Brain Tumor Microenvironment and Host State: Implications for Immunotherapy;Clinical Cancer Research;2019-02-25

5. Myeloablative Temozolomide Enhances CD8+ T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice;PLoS ONE;2013-03-18